Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 343,886 | 242,162 | 170,962 | 150,025 | 58,647 |
| Operating Income | -343,886 | -242,162 | -170,962 | -150,025 | -58,647 |
| Interest Expense | 0 | 0 | 0 | 0 | 396 |
| Other Income | 26,468 | 6,225 | 2,863 | 734 | -394 |
| Pre-tax Income | -317,418 | -235,937 | -168,099 | -149,291 | -59,437 |
| Net Income Continuous | -317,418 | -235,937 | -168,099 | -149,291 | -59,437 |
| Net Income | $-317,418 | $-235,937 | $-168,099 | $-149,291 | $-59,437 |
| EPS Basic Total Ops | -3.37 | -3.95 | -3.23 | -2.93 | -4.13 |
| EPS Basic Continuous Ops | -3.37 | -3.95 | -3.23 | -2.93 | -4.13 |
| EPS Diluted Total Ops | -3.37 | -3.95 | -3.23 | -2.93 | -4.13 |
| EPS Diluted Continuous Ops | -3.37 | -3.95 | -3.23 | -2.93 | -4.13 |
| EPS Diluted Before Non-Recurring Items | -3.37 | -3.95 | -3.23 | -2.93 | -4.13 |
| EBITDA(a) | $-345,817 | $-241,591 | $-168,003 | $-146,357 | $-57,871 |